Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1973 1
1974 2
1976 1
1977 2
1978 3
1979 4
1980 10
1981 4
1982 2
1983 4
1984 8
1985 6
1986 14
1987 11
1988 7
1989 11
1990 8
1991 9
1992 7
1993 8
1994 12
1995 14
1996 9
1997 8
1998 13
1999 6
2000 11
2001 11
2002 8
2003 8
2004 8
2005 10
2006 8
2007 11
2008 12
2009 8
2010 22
2011 11
2012 10
2013 13
2014 6
2015 12
2016 9
2017 2
2018 8
2019 9
2020 5
2021 3
2022 3
2023 8
2024 4
2025 2
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

388 results

Results by year

Filters applied: . Clear all
Page 1
OGDHL promotes prostate cancer progression and regulates neuroendocrine marker expression and nucleotide abundance.
Bernard MJ, Gallardo A, Ruiz A, Diaz JA, Nunley NM, Dove RN, Zhang S, Lee E, Heering KY, Varuzhanyan G, Bopardikar S, Hashimoto T, Agrawal R, Smith CM, Wilde BR, Matulionis N, Richards HM, Lee SCS, Sharifi MN, Lang JM, Zhao SG, Witte ON, Haffner MC, Shackelford DB, Boutros PC, Christofk HR, Goldstein AS. Bernard MJ, et al. Among authors: witte on. Mol Cancer Res. 2026 Jan 27:10.1158/1541-7786.MCR-25-0913. doi: 10.1158/1541-7786.MCR-25-0913. Online ahead of print. Mol Cancer Res. 2026. PMID: 41591383 Free PMC article.
Transcriptional profiling clarifies a program of enzalutamide extreme non-response in lethal prostate cancer.
Kumaraswamy A, Hu YM, Yates JA, Zhang C, Rodansky E, Khokhani D, Flores D, Duan Z, Zhang Y, Tabatabaei S, Slottke R, Ye S, Lara P, Foye A, Ryan CJ, Quigley DA, Huang J, Aggarwal R, Reiter RE, Wicha MS, Beer TM, Rettig M, Gleave M, Evans CP, Witte ON, Stuart JM, Thomas GV, Feng FY, Small EJ, Xia Z, Alumkal JJ. Kumaraswamy A, et al. Among authors: witte on. NPJ Precis Oncol. 2025 Jul 7;9(1):223. doi: 10.1038/s41698-025-01002-8. NPJ Precis Oncol. 2025. PMID: 40624104 Free PMC article.
Human cancer-targeted immunity via transgenic hematopoietic stem cell progeny.
Nowicki TS, Deen NNA, Peters CW, Comin-Anduix B, Medina E, Puig-Saus C, Carretero IB, Kaplan-Lefko P, Macabali MH, Garcilazo IP, Chen D, Pang J, Berent-Maoz B, Haile S, Rodriguez J, Kawakami M, Kidd CK, Champhekar A, Carlucci G, Vega-Crespo A, Chmielowski B, Singh A, Federman N, Schiller GM, Larson SJ, Allen-Auerbach M, Klomhaus AM, Zack J, Baltimore D, Yang L, Kohn DB, Witte ON, Ribas A. Nowicki TS, et al. Among authors: witte on. Nat Commun. 2025 Jul 1;16(1):5599. doi: 10.1038/s41467-025-60816-z. Nat Commun. 2025. PMID: 40593578 Free PMC article. Clinical Trial.
PGC-1α drives small cell neuroendocrine cancer progression toward an ASCL1-expressing subtype with increased mitochondrial capacity.
Varuzhanyan G, Chen CC, Freeland J, He T, Tran W, Song K, Wang L, Cheng D, Xu S, Dibernardo GA, Esedebe FN, Bhatia V, Han M, Abt ER, Park JW, Memarzadeh S, Shackelford DB, Lee JK, Graeber TG, Shirihai OS, Witte ON. Varuzhanyan G, et al. Among authors: witte on. Proc Natl Acad Sci U S A. 2024 Dec 3;121(49):e2416882121. doi: 10.1073/pnas.2416882121. Epub 2024 Nov 26. Proc Natl Acad Sci U S A. 2024. PMID: 39589879 Free PMC article.
Staggered immunization with mRNA vaccines encoding SARS-CoV-2 polymerase or spike antigens broadens the T cell epitope repertoire.
Abt ER, Lam AK, Noguchi M, Rashid K, McLaughlin J, Teng PL, Tran W, Cheng D, Nesterenko PA, Mao Z, Creech AL, Burton Sojo G, Jeyachandran AV, Tam YK, Henley JE, Comai L, Pardi N, Arumugaswami V, Witte ON, Radu CG, Wu TT. Abt ER, et al. Among authors: witte on. Proc Natl Acad Sci U S A. 2024 Dec 3;121(49):e2406332121. doi: 10.1073/pnas.2406332121. Epub 2024 Nov 26. Proc Natl Acad Sci U S A. 2024. PMID: 39589869 Free PMC article.
Genetic Screen in a Preclinical Model of Sarcoma Development Defines Drivers and Therapeutic Vulnerabilities.
Freeland J, Muñoz M, O'Donnell E 3rd, Langerman J, Darrow M, Bergonio J, Suarez-Navarro J, Thorpe S, Canter R, Randall RL, Plath K, Carraway KL 3rd, Witte ON, Graeber TG, Carr-Ascher JR. Freeland J, et al. Among authors: witte on. Clin Cancer Res. 2024 Nov 1;30(21):4957-4973. doi: 10.1158/1078-0432.CCR-24-1238. Clin Cancer Res. 2024. PMID: 39177582 Free PMC article.
Defining T cell receptor repertoires using nanovial-based binding and functional screening.
Koo D, Mao Z, Dimatteo R, Noguchi M, Tsubamoto N, McLaughlin J, Tran W, Lee S, Cheng D, de Rutte J, Burton Sojo G, Witte ON, Di Carlo D. Koo D, et al. Among authors: witte on. Proc Natl Acad Sci U S A. 2024 Apr 2;121(14):e2320442121. doi: 10.1073/pnas.2320442121. Epub 2024 Mar 27. Proc Natl Acad Sci U S A. 2024. PMID: 38536748 Free PMC article.
Temporal evolution reveals bifurcated lineages in aggressive neuroendocrine small cell prostate cancer trans-differentiation.
Chen CC, Tran W, Song K, Sugimoto T, Obusan MB, Wang L, Sheu KM, Cheng D, Ta L, Varuzhanyan G, Huang A, Xu R, Zeng Y, Borujerdpur A, Bayley NA, Noguchi M, Mao Z, Morrissey C, Corey E, Nelson PS, Zhao Y, Huang J, Park JW, Witte ON, Graeber TG. Chen CC, et al. Among authors: witte on. Cancer Cell. 2023 Dec 11;41(12):2066-2082.e9. doi: 10.1016/j.ccell.2023.10.009. Epub 2023 Nov 22. Cancer Cell. 2023. PMID: 37995683 Free PMC article.
388 results